Panacea Biotec Limited has informed the Exchange regarding a press release dated September 24, 2025, titled " Panacea Biotec Launches India s first 100% toxin-free and safe NikoMom Baby Skin Care ".
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.4 pts more than Nifty Microcap 250 and 4.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Panacea Biotec's wholly-owned subsidiary, Panacea Biotec Pharma Limited, has launched new baby care products under the NikoMom brand — Baby Massage Oil, Head to Toe Wash, Daily Lotion, and Diaper Rash Cream — marketed as India's first 100% toxin-free range. The subsidiary has also launched Staart Prime, an Infant Milk Substitute (IMS) product covering Stages 1 to 4. Both product lines are being rolled out in the domestic market on September 24, 2025, with international markets planned for a later date. The NikoMom skin care range complements the company's existing NikoMom Tape Diapers and Diaper Pants, extending its consumer baby care portfolio under the 7N Panacea Biotec consumer brand.
This is a brand extension within Panacea Biotec's growing consumer healthcare arm and should help diversify revenue beyond its core vaccines and pharma business. Short-term stock impact is likely limited as no revenue guidance or order size has been disclosed, but the move into the competitive domestic baby care and IMS segments could support long-term growth if the products gain market traction.